Analysen von Emily Field
| 08.11.22 | Bayer Overweight | Barclays Capital | |
| 02.11.22 | Bayer Overweight | Barclays Capital | |
| 02.11.22 | Merck Overweight | Barclays Capital | |
| 01.11.22 | AstraZeneca Overweight | Barclays Capital | |
| 27.10.22 | AstraZeneca Overweight | Barclays Capital | |
| 19.10.22 | Roche Overweight | Barclays Capital | |
| 18.10.22 | Roche Overweight | Barclays Capital | |
| 14.10.22 | Novo Nordisk Overweight | Barclays Capital | |
|
Werbung
|
|||
| 10.10.22 | Merck Overweight | Barclays Capital | |
| 07.10.22 | Merck Overweight | Barclays Capital | |
| 03.10.22 | Novo Nordisk Overweight | Barclays Capital | |
| 29.09.22 | Roche Overweight | Barclays Capital | |
| 31.08.22 | Bayer Overweight | Barclays Capital | |
| 29.08.22 | Bayer Overweight | Barclays Capital | |
| 16.08.22 | Merck Overweight | Barclays Capital | |
| 15.08.22 | Novo Nordisk Overweight | Barclays Capital | |
| 15.08.22 | Bayer Overweight | Barclays Capital | |
| 04.08.22 | Novo Nordisk Overweight | Barclays Capital | |
| 04.08.22 | AstraZeneca Overweight | Barclays Capital | |
| 04.08.22 | Merck Overweight | Barclays Capital | |
| 18.07.22 | Merck Overweight | Barclays Capital | |
| 18.07.22 | Novo Nordisk Overweight | Barclays Capital | |
| 18.07.22 | AstraZeneca Overweight | Barclays Capital | |
| 18.07.22 | Roche Overweight | Barclays Capital | |
| 18.07.22 | Bayer Overweight | Barclays Capital | |
| 15.07.22 | Bayer Overweight | Barclays Capital | |
| 22.06.22 | Bayer Overweight | Barclays Capital | |
| 21.06.22 | Bayer Overweight | Barclays Capital | |
| 13.06.22 | Novo Nordisk Overweight | Barclays Capital | |
| 10.06.22 | Bayer Overweight | Barclays Capital | |
| 12.05.22 | Merck Overweight | Barclays Capital | |
| 12.05.22 | Novo Nordisk Overweight | Barclays Capital | |
| 11.05.22 | Roche Overweight | Barclays Capital | |
| 11.05.22 | Bayer Overweight | Barclays Capital | |
| 10.05.22 | Bayer Overweight | Barclays Capital | |
| 04.05.22 | Merck Overweight | Barclays Capital | |
| 26.04.22 | Roche Overweight | Barclays Capital | |
| 04.04.22 | Bayer Overweight | Barclays Capital | |
| 30.03.22 | Roche Overweight | Barclays Capital | |
| 04.03.22 | Merck Overweight | Barclays Capital | |
| 15.02.22 | Novo Nordisk Overweight | Barclays Capital | |
| 15.02.22 | AstraZeneca Overweight | Barclays Capital | |
| 07.02.22 | Roche Overweight | Barclays Capital | |
| 04.02.22 | Roche Overweight | Barclays Capital | |
| 31.01.22 | Roche Overweight | Barclays Capital | |
| 31.01.22 | AstraZeneca Overweight | Barclays Capital | |
| 31.01.22 | Novo Nordisk Overweight | Barclays Capital | |
| 21.12.21 | Novo Nordisk Overweight | Barclays Capital | |
| 22.11.21 | Novo Nordisk Overweight | Barclays Capital | |
| 10.11.21 | AstraZeneca Overweight | Barclays Capital | |